Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. The company focuses on creating best-in-class mono and multispecific antibodies that target novel immune pathways, with an initial emphasis on atopic dermatitis and inflammatory bowel disease.